Ingemar Turesson
51 – 60 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.
(
- Contribution to journal › Letter
- 2011
-
Mark
The association of cancer and venous thrombosis: yes, Trousseau is right ... again!
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
(
- Contribution to journal › Article
-
Mark
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
(
- Contribution to journal › Article
-
Mark
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study
(
- Contribution to journal › Article
- 2010
-
Mark
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
(
- Contribution to journal › Scientific review
-
Mark
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance: to screen or not to screen for multiple myeloma? - response
(
- Contribution to journal › Letter
-
Mark
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
(
- Contribution to journal › Article